logo-loader
CNSX:CBII

CB2 Insights

Receive alerts
Market:
CNSX
Market Cap:
$12.84 m
Price
$0.17
Change
0.00%
52 weeks high
0.50
52 weeks low
0.15

Viewing results 1-25 of 28

Health

CB2 Insights names former Johnson & Johnson executive to its board of directors

Peter Cummins worked for more than two decades at Johnson & Johnson in a variety of executive roles...

2 weeks, 3 days ago
Health

Buds & Duds: Cannabis stocks in the green; CB2 Insights gets boost from former Johnson & Johnson executive

Also on the move were Cannvas MedTech, Harvest Health & Recreation, Canopy Growth and Choom...

2 weeks, 3 days ago
Health

Buds & Duds: Cannabis stocks inch down on Monday, but CB2 Insights on the rise

Also on the move were Curaleaf, Planet 13, Tilray and Isodiol International ...

3 weeks, 5 days ago
Tech

CB2 Insights expands data analytics platform to the UK through new medical cannabis pilot program

Project TWENTY21 is a new project to assess the efficacy, safety, quality of life and health outcomes for 20,000 patients using cannabinoid therapies in the UK...

4 weeks, 2 days ago
Health

Buds & Duds: Cannabis stocks flatten out Thursday; Aurora shares sink on downgrade

Also on the move were Terra Tech, CannTrust Holdings Inc, CB2 Insights and Curaleaf ...

4 weeks, 2 days ago
Tech

CB2 Insights advancing new medical cannabis evaluation tool, completes first phase of integration

Premier Health Group's Clinical Decision Support tool gives primary care physicians the resources and tools necessary to access the validity of medical cannabis as a treatment option ...

on 07/09/2019
Retail & consumer

Buds & Duds: Cannabis stocks lose steam but Namaste shares shine on pet product deal

Also on the move were FSD Pharma, CB2 Insights, Golden Leaf, Auxly and Acreage...

on 06/25/2019
Health

CB2 Insights to take over clinical cannabis care at six New Jersey facilities

The company is acquiring the assets of New Jersey Alternative Medicine...

on 06/25/2019
Tech

CB2 Insights announces new ticker symbol on OTC markets

The cannabis data analytics company will continue trading on the OTCQB under the new symbol 'CBIIF'...

on 05/17/2019
Health

CB2 Insights strengthens board with new member and appoints chairman

The cannabis data analytics company announced that it is welcoming Marc Adelson, deputy chief legal officer at Teladoc Inc, to its board of directors and appointing current board member David Danzinger as the company’s chairman...

on 05/02/2019
Health

CB2 Insights closes acquisition of cannabis evaluation clinics in Arizona and Colorado

The acquisition of MedEval Clinic provides CB2 with a network of clinics that offer cannabis evaluation and educational services...

on 04/10/2019
Health

CB2 Insights acquires Colorado-based Relaxed Clarity in a cash and stock deal; shares rise

It's the data analytics company's second acquisition of 2019...

on 04/04/2019
Health

Buds & Duds: Cannabis stocks slide on Thursday; CB2 Insights shares pop on acquisition

Also on the move were International Cannabis Corp, Planet 13 Holdings Inc and Isodiol International Inc ...

on 04/04/2019
Health

CB2 Insights says Premier Health begins adoption of cannabis-focused Clinical Decision Support tool

More than 4,600 physicians and other healthcare practitioners using Premier Health’s Juno electronic medical records platform will gain access to CB2's support tool...

on 03/27/2019
Health

CB2 Insights aims to be a cannabis data leader

The Toronto company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector...

on 03/22/2019
Health

CB2 Insights strikes deal to acquire MedEval Clinic

The deal marks the second clinical acquisition for the medical cannabis-focused data firm...

on 03/20/2019
Health

CB2 Insights names artificial intelligence pioneer as senior adviser to data insights division

There is a lack of medical cannabis data, according to the company, which is aiming to be a front-runner in filling demand...

on 03/14/2019